发明公开
- 专利标题： SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS
- 专利标题（中）： 对于中枢神经系统的合适的芳族砜化合物的疾病的治疗
-
申请号： EP10725883.2申请日： 2010-03-24
-
公开(公告)号： EP2521714A1公开(公告)日： 2012-11-14
- 发明人: NIROGI, Ramakrishna , SHINDE, Anil, Karbhari , KAMBHAMPATI, Rama, Sastri , BADANGE, Rajesh, Kumar , REBALLI, Veena , CHINDHE, Anil, Kashinath , NAMALA, Rambabu , MULLA, Mohamad, Sadik, Abdulhamid , AHMAD, Ishtiyaque , ABRAHAM, Renny , JASTI, Venkateswarlu
- 申请人： Suven Life Sciences Limited
- 申请人地址： Serene Chambers Road No. 5, Avenue 7, Banjara Hills Hyderabad 500 034, Andhra Pradesh IN
- 专利权人： Suven Life Sciences Limited
- 当前专利权人： Suven Life Sciences Limited
- 当前专利权人地址： Serene Chambers Road No. 5, Avenue 7, Banjara Hills Hyderabad 500 034, Andhra Pradesh IN
- 代理机构： Viering, Jentschura & Partner
- 优先权： INCH00182010 20100105
- 国际公布： WO2011083487 20110714
- 主分类号： C07D211/58
- IPC分类号： C07D211/58 ; C07D401/12 ; C07D401/14 ; A61K31/4468 ; A61K31/4709 ; A61K31/4725 ; A61P25/08 ; A61P25/18 ; A61P25/22 ; A61P25/24 ; A61P25/28 ; A61P29/00
摘要：
The present invention relates to novel sulfone compounds as 5-HT
6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT
6 receptor functions.
6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT
6 receptor functions.
公开/授权文献
信息查询
